In patients with idiopathic pulmonary fibrosis, 6-month treatment with IFN-γ and low dose prednisolone has been reported to reduce the levels of transcription of both TGF-ß1 and CTGF, and to improve lung function and blood gases [38]. This evidence concerns the gene CCN2 and idiopathic pulmonary fibrosis.